1 Agents affecting nervous system and sensory organs
|
|
2 Agents affecting individual organs
|
21 Cardiovascular agents
|
22 Respiratory organ agents
|
221 Respiratory stimulants
|
222 Antitussives
|
223 Expectorants
|
224 Antitussives and expectorants
|
225 Bronchodilators
|
226 Gargles
|
229 Miscellaneous
|
2290 Miscellaneous
|
D00246 Budesonide (JP18/USP/INN)
D00689 Beclomethasone dipropionate (USP); Beclometasone dipropionate (JP18)
D00690 Mometasone furoate (JAN/USP)
D06315 Fluticasone furoate (JAN/USAN/INN)
D01708 Fluticasone propionate (JAN/USP)
D05803 Sargramostim (USP/INN); Sargramostim (genetical recombination) (JAN)
D01703 Ciclesonide (JAN/USAN/INN)
D08699 Salmeterol xinafoate and fluticasone propionate
D09595 Budesonide and formoterol fumarate dihydrate
D10501 Fluticasone furoate and vilanterol trifenatate
D10506 Fluticasone propionate and formoterol fumarate hydrate
D11862 Indacaterol and mometasone furoate
D11035 Fluticasone furoate, umeclidinium bromide and vilanterol
D11584 Budesonide, glycopyrronium bromide and formoterol fumarate
D11861 Indacaterol acetate, glycopyrronium bromide and mometasone furoate
D05251 Omalizumab (USAN/INN); Omalizumab (genetical recombination) (JAN)
D04923 Mepolizumab (USAN/INN); Mepolizumab (genetical recombination) (JAN)
D09874 Benralizumab (USAN/INN); Benralizumab (genetical recombination) (JAN)
D11771 Tezepelumab (USAN/INN); Tezepelumab (genetical recombination) (JAN)
D03261 Tyloxapol (JAN/USP/INN)
D03896 Dornase alfa (USAN/INN); Dornase alfa (genetical recombination) (JAN)
D11693 Gefapixant citrate (JAN/USAN)
|
23 Digestive organ agents
|
24 Hormones
|
25 Urogenital and anal organ agents
|
26 Epidermides
|
27 Dental preparations
|
29 Other agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|